首页> 外文OA文献 >The role of ezetimibe in LDL cholesterol goal attainment in very high risk patients: the rosuvastatin monotherapy looks to be insufficient

【2h】

The role of ezetimibe in LDL cholesterol goal attainment in very high risk patients: the rosuvastatin monotherapy looks to be insufficient

机译：依泽替米贝在极高风险患者中达到LDL胆固醇目标的作用：瑞舒伐他汀单药治疗似乎不足

页面导航

著录项
相似文献
相关主题

著录项

作者
Márk László; Paragh György; Reiber István;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
中文文献
专利

1. The role of ezetimibe in LDL cholesterol goal attainment in very high risk patients: The rosuvastatin monotherapy looks to be insufficient [J] . MarkL., ParaghG., ReiberI. Current medical research and opinion . 2011 ,第10期

机译：依泽替米贝在极高风险患者中降低LDL胆固醇目标中的作用：瑞舒伐他汀单一疗法似乎不足
2. Switching from statin monotherapy to ezetimibe/simvastatin or rosuvastatin modifies the relationships between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients at high risk of coronary disease. [J] . Vaverkova H, Farnier M, Averna M, Clinical Biochemistry . 2011 ,第8a9期

机译：从他汀类药物单一疗法切换到依泽替米贝/辛伐他汀或瑞舒伐他汀可以改变冠心病高风险患者载脂蛋白B，LDL胆固醇和非HDL胆固醇之间的关系。
3. The role of ezetimibe in LDL cholesterol goal attainment in very high risk patients [J] . MikhailidisD.P., LawsonR.W., McCormickA.-L., Current medical research and opinion . 2011 ,第10期

机译：依泽替米贝在极高风险患者中降低LDL胆固醇目标中的作用
4. Risk Stratification for LDL Cholesterol using Induction Technique [C] . Seung Hee Ho, Hyun Young Park, Yang Soo Jang, MEDINFO . 2007

机译：使用感应技术的LDL胆固醇风险分层
5. The effect of fish oil supplementation on LDL cholesterol subclasses in patients with type 2 diabetes mellitus. [D] . Thompson, Marion E. 2003

机译：补充鱼油对2型糖尿病患者LDL胆固醇亚类的影响。
6. Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin atorvastatin or rosuvastatin compared with titrating statin monotherapy [O] . JoAnne M Foody, Peter P Toth, Joanne E Tomassini, 2013

机译：与滴定他汀单一疗法相比辛伐他汀阿托伐他汀或瑞舒伐他汀添加依泽替米贝相关的LDL-C水平和目标达成的变化
7. PCV17 Attainment of ldl-cholesterol goals is suboptimal with rosuvastatin monotherapy in us patients at high cardiovascular risk [O] . Marrett E., Zhang Q., Zhao C., 2013

机译：瑞舒伐他汀单药治疗对心血管风险高的美国患者而言，PCV17达到Idl-胆固醇目标的效果欠佳

The role of ezetimibe in LDL cholesterol goal attainment in very high risk patients: the rosuvastatin monotherapy looks to be insufficient

著录项

相似文献

相关主题

期刊订阅